Pharmacist Letter: July 2016; Vol: 32, No. 7
In search for online readings for your CPE points? Pharmacist’s Letter is also a recognized online CPE provider by the Singapore Pharmacy Council!
What are you waiting for? Log into the PSS website with your membership number and password to access Pharmacist Letter now! Here are the interesting topics for the month of July 2016.
What’s New on Pharmacist Letter: July 2016; Vol: 32, No. 7
Topic of the month: Communicating with Empathy
Putting yourself in your patient's shoes and respecting their point of view may make them more likely to open up to you. This can help bridge information gaps and enhance patient care. But this may be tricky in a busy pharmacy, where stress levels are high and plenty of competing demands to be filled. Find out how to balance between busy work schedules and getting the best out of each patient interaction section with this CE: Strategies for Communicating Effectively with Patients
Clinical updates:
- Management of Hepatitis C can be a rather complex process with different medication regimes. Check out the PL chart for a comprehensive guide on the types of Hepatitis C treatment regimen options for adults based on genotype, presence of cirrhosis, and treatment history.
-
Dosing low molecular weight heparin in special populations can be tricky, as outcome data are limited. Extremes in weight and renal impairment may affect pharmacokinetics. Confused over how to do it? Listen to the latest PL Voices, a discussion between two experts on the appropriate dosing of low molecular weight heparin in special patient populations.
Frequently asked questions at the community pharmacy:
- Is there an OTC remedy for my insomnia?
Are you aware of the natural medicines which can be used to treat insomnia?
Read more about it in this CE: Natural Medicines in the Clinical Management of Insomnia
- I heard that Imodium is linked to death. Should I be worried about it?
Loperamide also known as “poor-man’s methadone”, is recently linked with many cases of abuse, resulting in death. This was widely reported in the United States where it is an OTC medication. Find out more in this PL Update
